Literature DB >> 11069876

Migraine prophylaxis in adult patients.

D Parsekyan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11069876      PMCID： PMC1071161          DOI： 10.1136/ewjm.173.5.341

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  24 in total

Review 1.  Taking control of migraine and headache.

Authors:  L Knott
Journal:  Practitioner       Date:  1999-01

2.  Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study.

Authors:  V Pfaffenrath; P Wessely; C Meyer; H R Isler; S Evers; K H Grotemeyer; Z Taneri; D Soyka; H Göbel; M Fischer
Journal:  Cephalalgia       Date:  1996-10       Impact factor: 6.292

Review 3.  Prophylactic treatment of migraine: evaluation of clinical trials and choice among drugs.

Authors:  P Tfelt-Hansen
Journal:  Cephalalgia       Date:  1995-10       Impact factor: 6.292

4.  Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects.

Authors:  J R Couch; D K Ziegler; R Hassanein
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

5.  Preventing migraine: a study of precipitating factors.

Authors:  J N Blau; M Thavapalan
Journal:  Headache       Date:  1988-08       Impact factor: 5.887

Review 6.  Evidence based migraine prophylactic drug therapy.

Authors:  W J Becker
Journal:  Can J Neurol Sci       Date:  1999-11       Impact factor: 2.104

7.  Migraine prophylaxis with divalproex.

Authors:  N T Mathew; J R Saper; S D Silberstein; L Rankin; H G Markley; S Solomon; A M Rapoport; C J Silber; R L Deaton
Journal:  Arch Neurol       Date:  1995-03

8.  Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.

Authors:  R Jensen; T Brinck; J Olesen
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

9.  Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.

Authors:  A Peikert; C Wilimzig; R Köhne-Volland
Journal:  Cephalalgia       Date:  1996-06       Impact factor: 6.292

10.  Amitriptyline in migraine prophylaxis.

Authors:  J R Couch; R S Hassanein
Journal:  Arch Neurol       Date:  1979-11
View more
  5 in total

Review 1.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

2.  Migraine management: How do the adult and paediatric migraines differ?

Authors:  M Sonal Sekhar; Shalini Sasidharan; Siby Joseph; Anand Kumar
Journal:  Saudi Pharm J       Date:  2011-07-20       Impact factor: 4.330

3.  Effect of NOS3 gene polymorphism on response to Tricyclic antidepressants in migraine attacks.

Authors:  Aliasghar Molana; Masoud Mehrpour; Nasim Vousooghi; Mahmoud Reza Hajighasem; Mohammad Taghi Joghataei
Journal:  Iran J Neurol       Date:  2014-07-04

4.  Treatment adherence among new triptan users: a 2-year cohort study in Taiwan.

Authors:  Ting-Bin Chen; Yung-Tai Chen; Jong-Ling Fuh; Chao-Hsiun Tang; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2014-08-12       Impact factor: 7.277

5.  Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies.

Authors:  Koichi Hirata; Takao Takeshima; Fumihiko Sakai; Noboru Imai; Yasuhiko Matsumori; Yoshihisa Tatsuoka; Yotaro Numachi; Ryuji Yoshida; Cheng Peng; Daniel D Mikol; Gabriel Paiva da Silva Lima; Sunfa Cheng
Journal:  Brain Behav       Date:  2022-02-24       Impact factor: 2.708
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.